Navigation Links
Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award
Date:9/9/2011

BOSTON, Sept. 9, 2011 /PRNewswire/ -- Mass High Tech has selected Greenberg Traurig shareholder Jennifer A. Camacho to be a recipient of its 2011 All-Stars Award, one that recognizes 15 driven and influential leaders of New England's innovation economy.  

Camacho will be recognized for her wide range of experience in and contribution to the life sciences sector.  As a patent attorney, she represents pharmaceutical and biotechnology clients. Camacho brings a real-world perspective to client representation from her tenure as chief patent counsel, vice president of intellectual property and general counsel at a venture-backed start-up company in the emerging field of synthetic biology and DNA synthesis.  She is a founding team member for the International Consortium for Polynucleotide Synthesis, Inc., and currently serves on the board of directors for the Center for Policy on Emerging Technologies in Washington, D.C.  In addition,  Camacho serves as a judge and mentor for the MassChallenge, Inc. annual startup competition and accelerator program.

"The 2011 All-Stars have a proven record in leading not only their own companies but in helping their industry thrive and in guiding entrepreneurs who are building the successful tech companies of tomorrow," said Mass High Tech publisher Doug Banks.  "The companies and industries that they have helped to build are the basis of the economic engine that provides jobs and spawns innovation throughout New England and the United States."

Honorees will be profiled in a special report on MassHighTech.com and recognized at an evening awards celebration and networking reception on Wednesday, November 16th, at the House of Blues in Boston.

About Greenberg Traurig, LLP

Greenberg Traurig, LLP is an international, full-service law firm with approximately 1,800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2011 NLJ 250. In the U.K., the firm operates as Greenberg Traurig Maher LLP. Greenberg Traurig has a strategic alliance with the independent law firm, Studio Santa Maria in Milan and Rome. The firm was Chambers and Partners' USA Law Firm of the Year in 2007 and among the Top 3 in the International Law Firm of the Year at the 2009 The Lawyer Awards. For additional information, please visit www.gtlaw.com.


'/>"/>
SOURCE Greenberg Traurig, LLP
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
3. Mymetics Corporation Important Shareholders Information Conference Call
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche
6. Chromos announces shareholder approval of Arrangement
7. Sangui Bio Tech International Inc. Shareholders Meeting Delayed to Include FY 2008 Report
8. ARIUS sale approved by shareholders
9. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
10. China-Biotics, Inc. Announces Results of 2008 Annual General Meeting of Shareholders
11. Insmed to Seek Shareholder Approval for Reverse Split
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... DIEGO , Feb. 5, 2016 On ... region,s trusted information source for community, health and disaster ... Diego) will integrate to enhance care coordination and ... to the services they need and to better connect ... improve care.   San Diego ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... SHENZHEN, China , Feb. 4, 2016 ... government, and various medical institutions attended a ceremony in ... provide integrative, personalized cell therapy in 2016. ... the "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" ... Shenzhen Regional Cell Production Center, both subsidiaries of Beike ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 4, 2016 --> ... to SEK 1,351.5 M (105.0), up 1,187% compared with fourth quarter of ... amounted to SEK 517.6 M (loss: 30.0). Earnings per share ... activities was SEK 537.4 M (neg: 74.7). , ... , Revenues amounted to SEK 2,900.5 M (233.6), up 1,142% compared with ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... analysis of the bioinformatic market by reviewing the ... computer enabled tools that drive the field forward. ... report to: Identify the challenges and opportunities ... service providers and software solution developers, as well ...
(Date:2/1/2016)... BURNABY, Canada , February 1, 2016 ... new technological advancements to drive global touchfree intuitive gesture ...   --> Rising sales of consumer electronics ... intuitive gesture control market size ... of consumer electronics coupled with new technological advancements to ...
Breaking Biology News(10 mins):